SeaStar Medical executive granted 7,500 RSUs

SeaStar Medical Holding Corp executive Towne Bradford K reported receiving 7,500 shares of common stock as a stock-based award.

Accepted by SEC EDGAR 02/10/2026 - 04:56 PM EST Learn about SEC filing dates

Rhea-AI Filing Summary

SeaStar Medical Holding Corp executive Towne Bradford K reported receiving 7,500 shares of common stock as a stock-based award. The shares, reported at a price of $0 per share, increased the executive's directly held stake to 9,050 shares.

The award is in the form of restricted stock units that vest in three equal installments on the first, second and third anniversaries of February 6, 2026. Towne Bradford K serves as the company's Principal Accounting Officer.

Insider Trade Summary

Grant/Award: 7,500 shares

Grant/Award 1 txn

Insider Towne Bradford K

Role Principal Accounting Officer

Type	Security	Shares	Price	Value
Grant/Award	Common Stock, par value $0.0001	7,500	$0.00	$0.00

Holdings After Transaction: Common Stock, par value $0.0001 — 9,050 shares (Direct)

Footnotes (1)

1. F1. Represents an RSU award. The RSU award vests in equal installments on the first, second and third anniversaries of February 6, 2026

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did SeaStar Medical (ICU) report for Towne Bradford K?

Towne Bradford K received 7,500 shares of SeaStar Medical common stock as a stock-based award. The Form 4 shows an acquisition at $0 per share, reported as a grant that increased directly held shares to 9,050.

What type of equity award did Towne Bradford K receive from SeaStar Medical (ICU)?

The filing reports a restricted stock unit (RSU) award of 7,500 shares. These RSUs convert into common stock over time as they vest, rather than being immediately unrestricted shares on the grant date.

How do the RSUs granted to Towne Bradford K at SeaStar Medical (ICU) vest?

The RSU award vests in three equal annual installments. Vesting occurs on the first, second and third anniversaries of February 6, 2026, gradually delivering the underlying common shares to the executive over that period.

How many SeaStar Medical (ICU) shares does Towne Bradford K own after this Form 4 transaction?

After the reported RSU-related acquisition, Towne Bradford K beneficially owns 9,050 shares. The ownership is reported as direct, meaning the shares are held in the executive’s own name rather than through an intermediary entity.

What role does Towne Bradford K hold at SeaStar Medical (ICU)?

Towne Bradford K serves as Principal Accounting Officer at SeaStar Medical Holding Corp. This officer role is disclosed in the Form 4, which reports the equity award and corresponding change in directly owned common shares.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Towne Bradford K

(Last) (First) (Middle)

3513 BRIGHTON BLVD

SUITE 410

(Street)

DENVER CO 80216

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
SeaStar Medical Holding Corp [ ICU ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Principal Accounting Officer

3. Date of Earliest Transaction (Month/Day/Year)
02/06/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock, par value $0.0001	02/06/2026		A		7,500(1)	A	$0	9,050	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents an RSU award. The RSU award vests in equal installments on the first, second and third anniversaries of February 6, 2026

Remarks:

Ex. 24.1 - Power of Attorney

	/s/ Eric Schlorff as-attorney-in-fact	02/10/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.